The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Thursday, August 13, 2026

Subject of the day

PEN

Concerning the House

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

United States · www.penumbrainc.com

The Long Run

FY 2015–2025 · 11 years

LineLatestCAGRTrend
Revenue$1.06B+42.1%
Gross profit$755.00M+24.7%
Operating income$73.55M+50.6%
Net income$177.69M+61.6%
Cash from ops$97.33M+38.2%
Quotation

$326.75

+0.17 (+0.1%)

52w hi$359.40
52w lo$225.54
Vol130.43K
As ofAug 13
The Verdict

Hold

Our score -0.02

Short-0.04
Medium+0.09
Long-0.17

computed 2026-08-13

By the Numbers

Penumbra, Inc.

Healthcare · Medical Devices

Market cap$12.87B
Enterprise value$12.42B
Trailing P/E80.09x
Forward P/E53.29x
EV / EBITDA60.79x
P / S (ttm)8.55x
Profit margin10.7%
Return on equity11.4%
Revenue growth+14.9%
Earnings growth-23.5%
Debt / equity13.90
Risk Metrics
Beta vs SPX0.59
Corr SPX0.28
Annual vol35.0%
Annual ret+38.1%
Sharpe1.09
Max DD-25.8%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.03
Sector+0.12
Technical+0.00
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$327.25$327.58$326.04$326.75130.43K
Aug 12$325.60$327.55$325.25$326.58230.00K
Aug 11$325.79$326.83$325.39182.56K
Aug 10$324.90$326.49$324.90$325.98194.70K
Aug 7$324.93$325.74$324.46$324.66239.50K